Journal of Genetic Counseling

, Volume 18, Issue 1, pp 42–48 | Cite as

The Impact of Social Roles on the Experience of Men in BRCA1/2 Families: Implications for Counseling

  • Mary B. DalyEmail author


Recent advances in genetics have identified several genes associated with inherited susceptibility to breast and ovarian cancer and have led to the commercial availability of mutation analyses. Although the majority of cancers associated with BRCA1/2 mutations are seen in women, men with BRCA1/2 mutations are at increased risk for male breast cancer, prostate cancer, pancreatic cancer and melanoma. Limited data available on the response of men in BRCA1/2 families suggest that the majority do not pursue genetic counseling, thus they may forgo the opportunity to improve health practices and to pass on valuable cancer risk information to offspring. The patterns of relationships of men within the family and society can pose challenges to their recognition of genetic health threats and the need for preventive interventions. Genetic counselors are in a position to inform at-risk males of their genetic risk, and to help them explore their personal health options.


Hereditary cancer BRCA1/2 mutations Genetic counseling Male family members 



The author would like to acknowledge the assistance of Lorraine Crozier in the preparation of the manuscript. This publication was supported by grant number P30 CA006927 from the National Cancer Institute. Its contents are solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.


  1. Beare, H., & Priddy, N. (1999). The cancer guide for men. London NW1: Sheldon Press.Google Scholar
  2. Beery, T. A., & Williams, J. K. (2007). Risk reduction and health promotion behaviors following genetic testing for adult-onset disorders. Genetic Testing, 11(2), 111–123. doi: 10.1089/gte.2006.0527.PubMedCrossRefGoogle Scholar
  3. Bowen, D. J., Bourcier, E., Press, N., Lewis, F. M., & Burke, W. (2004). Effects of individual and family functioning on interest in genetic testing. Community Genetics, 7(1), 25–32. doi: 10.1159/000080301.PubMedCrossRefGoogle Scholar
  4. Brooks, G. R. (2001). Masculinity and men’s mental health. Journal of American College Health, 49(6), 285–297.PubMedGoogle Scholar
  5. Brose, M. S., Rebbeck, T. R., Calzone, K. A., Stopfer, J. E., Nathanson, K. L., & Weber, B. L. (2002). Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. Journal of the National Cancer Institute, 94(18), 1365–1372.PubMedGoogle Scholar
  6. Claes, E., Evers-Kiebooms, G., Boogaerts, A., Decruyenaere, M., Denayer, L., & Legius, E. (2003). Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. American Journal of Medical Genetics. Part A, 116(1), 11–19.Google Scholar
  7. Connell, R. W., & Messerschmidt, J. W. (2005). Hegemonic masculinity: rethinking the concept. Gender and Society, 19(6), 829–859. doi: 10.1177/0891243205278639.CrossRefGoogle Scholar
  8. Courtenay, W. H. (2000). Constructions of masculinity and their influence on men’s well-being: a theory of gender and health. Social Science & Medicine, 50(10), 1385–1401. doi: 10.1016/S0277-9536(99)00390-1.CrossRefGoogle Scholar
  9. Creighton, S., Almqvist, E. W., MacGregor, D., Fernandez, B., Hogg, H., Beis, J., et al. (2003). Predictive, pre-natal and diagnostic genetic testing for Huntington’s disease: the experience in Canada from 1987 to 2000. Clinical Genetics, 63(6), 462–475. doi: 10.1034/j.1399-0004.2003.00093.x.PubMedCrossRefGoogle Scholar
  10. d’Agincourt-Canning, L. (2001). Experiences of genetic risk: disclosure and the gendering of responsibility. Bioethics, 15(3), 231–247.PubMedCrossRefGoogle Scholar
  11. Daly, P. A., Nolan, C., Green, A., Ormiston, W., Cody, N., McDevitt, T., et al. (2003). Predictive testing for BRCA1 and 2 mutations: a male contribution. Annals of Oncology, 14(4), 549–553.PubMedCrossRefGoogle Scholar
  12. Davies, J., McCrae, B. P., Frank, J., Dochnahl, A., Pickering, T., Harrison, B., et al. (2000). Identifying male college students’ perceived health needs, barriers to seeking help, and recommendations to help men adopt healthier lifestyles. Journal of American College Health, 48(6), 259–267.PubMedGoogle Scholar
  13. DeMarco, T. A., & McKinnon, W. C. (2006). Life after BRCA1/2 testing: family communication and support issues. Breast Diseases, 27, 127–136.Google Scholar
  14. Dube, C. E., & Fuller, B. K. (2003). A qualitative study of communication skills for male cancer screening discussions. Journal of Cancer Education, 18(4), 182–187.PubMedCrossRefGoogle Scholar
  15. Dudok De Wit, A. C., Tibben, A., Frets, P. G., NMeijers-Heijboer, E. J., Devilee, P., & Niermeijer, M. F. (1996). Males at-risk for the BRCA1-gene, the psychological impact. Psycho-oncology, 5, 251–257.CrossRefGoogle Scholar
  16. Edwards, S. M., Kote-Jarai, Z., Meitz, J., Hamoudi, R., Hope, Q., Osin, P., et al. (2003). Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. American Journal of Human Genetics, 72(1), 1–12.PubMedCrossRefGoogle Scholar
  17. Finlay, E., Stopfer, J. E., Burlingame, E., Evans, K. G., Nathanson, K. L., Weber, B. L., et al. (2008). Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. Genetic Testing, 12(1), 81–91.PubMedCrossRefGoogle Scholar
  18. Foster, C., Evans, D. G., Eeles, R., Eccles, D., Ashley, S., Brooks, L., et al. (2002). Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort. British Journal of Cancer, 86(8), 1209–1216.PubMedCrossRefGoogle Scholar
  19. Friedman, L. S., Gayther, S. A., Kurosaki, T., Gordon, D., Noble, B., Casey, G., et al. (1997). Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. American Journal of Human Genetics, 60(2), 313–319.PubMedGoogle Scholar
  20. Gayther, S. A., Mangion, J., Russell, P., Seal, S., Barfoot, R., Ponder, B. A., et al. (1997). Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nature Genetics, 15(1), 103–105.PubMedCrossRefGoogle Scholar
  21. Glanz, K., Grove, J., Lerman, C., Gotay, C., & Le Marchand, L. (1999). Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups. Cancer Epidemiology, Biomarkers & Prevention, 8(4 Pt 2), 329–336.Google Scholar
  22. Gough, B. (2006). Try to be healthy, but don’t forgo your masculinity: deconstructing men’s health discourse in the media. Social Science & Medicine, 63(9), 2476–2488.CrossRefGoogle Scholar
  23. Gray, R. E., Fitch, M., Phillips, C., Labrecque, M., & Fergus, K. (2000). Managing the impact of illness: the experiences of men with prostate cancer and their spouses. Journal of Health Psychology, 5(4), 531–548.Google Scholar
  24. Green, J., Richards, M., Murton, F., Statham, H., & Hallowell, N. (1997). Family communication and genetic counseling: the case of hereditary breast and ovarian cancer. Journal of Genetic Counseling, 6(1), 45–60.CrossRefGoogle Scholar
  25. Hadley, D. W., Jenkins, J., Dimond, E., Nakahara, K., Grogan, L., Liewehr, D. J., et al. (2003). Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Archives of Internal Medicine, 163(5), 573–582.PubMedCrossRefGoogle Scholar
  26. Hagoel, L., Dishon, S., Almog, R., Silman, Z., Bisland-Becktell, S., & Rennert, G. (2000). Proband family uptake of familial-genetic counselling. Psycho-oncology, 9(6), 522–527.PubMedCrossRefGoogle Scholar
  27. Hall, J. M., Lee, M. K., Newman, B., Morrow, J. E., Anderson, L. A., Huey, B., et al. (1990). Linkage of early-onset familial breast cancer to chromosome 17q21. Science, 250(4988), 1684–1689.PubMedCrossRefGoogle Scholar
  28. Hallowell, N., Arden-Jones, A., Eeles, R., Foster, C., Lucassen, A., Moynihan, C., et al. (2006). Guilt, blame and responsibility: men’s understanding of their role in the transmission of BRCA1/2 mutations within their family. Sociology of Health and Illness, 28(7), 969–988.PubMedGoogle Scholar
  29. Hallowell, N., Ardern-Jones, A., Eeles, R., Foster, C., Lucassen, A., Moynihan, C., et al. (2005a). Men’s decision-making about predictive BRCA1/2 testing: the role of family. Journal of Genetic Counseling, 14(3), 207–217.PubMedCrossRefGoogle Scholar
  30. Hallowell, N., Ardern-Jones, A., Eeles, R., Foster, C., Lucassen, A., Moynihan, C., et al. (2005b). Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems. Clinical Genetics, 67(6), 492–502.PubMedCrossRefGoogle Scholar
  31. Hallowell, N., Foster, C., Eeles, R., Ardern-Jones, A., Murday, V., & Watson, M. (2003). Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information. Journal of Medical Ethics, 29(2), 74–79 discussion 80–73.PubMedCrossRefGoogle Scholar
  32. Hamilton, R. J., Bowers, B. J., & Williams, J. K. (2005). Disclosing genetic test results to family members. Journal of Nursing Scholarship, 37(1), 18–24.PubMedCrossRefGoogle Scholar
  33. Harris, M., Winship, I., & Spriggs, M. (2005). Controversies and ethical issues in cancer-genetics clinics. Lancet Oncology, 6(5), 301–310.PubMedCrossRefGoogle Scholar
  34. Hong, L. (2000). Toward a transformed approach to prevention: breaking the link between masculinity and violence. Journal of American College Health, 48(6), 269–279.PubMedGoogle Scholar
  35. Horsburgh, S., Matthew, A., Bristow, R., & Trachtenberg, J. (2005). Male BRCA1 and BRCA2 mutation carriers: a pilot study investigating medical characteristics of patients participating in a prostate cancer prevention clinic. Prostate, 65(2), 124–129.PubMedCrossRefGoogle Scholar
  36. Hughes, C., Lerman, C., Schwartz, M., Peshkin, B. N., Wenzel, L., Narod, S., et al. (2002). All in the family: evaluation of the process and content of sisters’ communication about BRCA1 and BRCA2 genetic test results. American Journal of Medical Genetics, 107(2), 143–150.PubMedCrossRefGoogle Scholar
  37. Hyde, J. S. (2005). The gender similarities hypothesis. American Psychologist, 60(6), 581–592.PubMedCrossRefGoogle Scholar
  38. Julian-Reynier, C., Eisinger, F., Chabal, F., Lasset, C., Nogues, C., Stoppa-Lyonnet, D., et al. (2000). Disclosure to the family of breast/ovarian cancer genetic test results: patient’s willingness and associated factors. American Journal of Medical Genetics, 94(1), 13–18.PubMedCrossRefGoogle Scholar
  39. King, M. C., Rowell, S., & Love, S. M. (1993). Inherited breast and ovarian cancer. What are the risks? What are the choices? JAMA, 269(15), 1975–1980.PubMedCrossRefGoogle Scholar
  40. Klitzman, R., Thorne, D., Williamson, J., Chung, W., & Marder, K. (2007). Disclosures of Huntington disease risk within families: patterns of decision-making and implications. American Journal of Medical Genetics A, 143(16), 1835–1849.CrossRefGoogle Scholar
  41. Lerman, C., Hughes, C., Trock, B. J., Myers, R. E., Main, D., Bonney, A., et al. (1999). Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA, 281(17), 1618–1622.PubMedCrossRefGoogle Scholar
  42. Liede, A., Karlan, B. Y., & Narod, S. A. (2004). Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. Journal of Clinical Oncology, 22(4), 735–742.PubMedCrossRefGoogle Scholar
  43. Liede, A., Metcalfe, K., Hanna, D., Hoodfar, E., Snyder, C., Durham, C., et al. (2000). Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling. American Journal of Human Genetics, 67(6), 1494–1504.PubMedCrossRefGoogle Scholar
  44. Lodder, L., Frets, P. G., Trijsburg, R. W., Tibben, A., Meijers-Heijboer, E. J., Duivenvoorden, H. J., et al. (2001). Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing. European Journal of Human Genetics, 9(7), 492–500.PubMedCrossRefGoogle Scholar
  45. Maat-Kievit, A., Vegter-van der Vlis, M., Zoeteweij, M., Losekoot, M., van Haeringen, A., & Roos, R. (2000). Paradox of a better test for Huntington’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 69(5), 579–583.CrossRefGoogle Scholar
  46. Marteau, T. M., Dundas, R., & Axworthy, D. (1997). Long-term cognitive and emotional impact of genetic testing for carriers of cystic fibrosis: the effects of test result and gender. Health Psychology, 16(1), 51–62.PubMedCrossRefGoogle Scholar
  47. McAllister, M. F., Evans, D. G., Ormiston, W., & Daly, P. (1998). Men in breast cancer families: a preliminary qualitative study of awareness and experience. Journal of Medical Genetics, 35(9), 739–744.PubMedCrossRefGoogle Scholar
  48. Meiser, B., Collins, V., Warren, R., Gaff, C., St John, D. J., Young, M. A., et al. (2004). Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer. Clinical Genetics, 66(6), 502–511.PubMedCrossRefGoogle Scholar
  49. Nicholas, D. R. (2000). Men, masculinity, and cancer: risk-factor behaviors, early detection, and psychosocial adaptation. Journal of American College Health, 49(1), 27–33.PubMedGoogle Scholar
  50. Ottini, L., Masala, G., D’Amico, C., Mancini, B., Saieva, C., Aceto, G., et al. (2003). BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Cancer Research, 63(2), 342–347.PubMedGoogle Scholar
  51. Patenaude, A. F., Dorval, M., DiGianni, L. S., Schneider, K. A., Chittenden, A., & Garber, J. E. (2006). Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. Journal of Clinical Oncology, 24(4), 700–706.PubMedCrossRefGoogle Scholar
  52. Peterson, E. A., Milliron, K. J., Lewis, K. E., Goold, S. D., & Merajver, S. D. (2002). Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. Cancer Epidemiology, Biomarkers & Prevention, 11(1), 79–87.Google Scholar
  53. Peterson, S. K., Watts, B. G., Koehly, L. M., Vernon, S. W., Baile, W. F., Kohlmann, W. K., et al. (2003). How families communicate about HNPCC genetic testing: findings from a qualitative study. American Journal of Medical Genetics Part C Seminars in medical genetics, 119(1), 78–86.Google Scholar
  54. Pfeffer, N. L., Veach, P. M., & LeRoy, B. S. (2003). An investigation of genetic counselors’ discussion of genetic discrimination with cancer risk patients. Journal of Genetic Counseling, 12(5), 419–438.PubMedCrossRefGoogle Scholar
  55. Roter, D., & Hall, J. (1992). Doctors talking with patients/patients talking with doctors: improving communication in medical visits. CT: Greenwood Publishing Group.Google Scholar
  56. Schofield, T., Connell, R. W., Walker, L., Wood, J. F., & Butland, D. L. (2000). Understanding men’s health and illness: a gender-relations approach to policy, research, and practice. Journal of American College Health, 48(6), 247–256.PubMedCrossRefGoogle Scholar
  57. Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., et al. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New England Journal of Medicine, 336(20), 1401–1408.PubMedCrossRefGoogle Scholar
  58. Taylor, S. (2005). Gender differences in attitudes among those at risk for Huntington’s disease. Genetic Testing, 9(2), 152–157.PubMedCrossRefGoogle Scholar
  59. Thompson, D., & Easton, D. (2001). Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. American Journal of Human Genetics, 68(2), 410–419.PubMedCrossRefGoogle Scholar
  60. Thompson, D., & Easton, D. F. (2002). Cancer Incidence in BRCA1 mutation carriers. Journal of the National Cancer Institute, 94(18), 1358–1365.PubMedGoogle Scholar
  61. van Oostrom, I., Meijers-Heijboer, H., Duivenvoorden, H. J., Brocker-Vriends, A. H., van Asperen, C. J., Sijmons, R. H., et al. (2007). Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study. Clinical Genetics, 71(1), 35–42.PubMedCrossRefGoogle Scholar
  62. Wagner Costalas, J., Itzen, M., Malick, J., Babb, J. S., Bove, B., Godwin, A. K., et al. (2003). Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program’s experience. American Journal of Medical Genetics Part C Seminars in medical genetics, 119(1), 11–18.Google Scholar
  63. Welkenhuysen, M., Evers-Kiebooms, G., Decruyenaere, M., Claes, E., & Denayer, L. (2001). A community based study on intentions regarding predictive testing for hereditary breast cancer. Journal of Medical Genetics, 38(8), 540–547.PubMedCrossRefGoogle Scholar
  64. White, R. (2002). Social and political aspects of men’s health. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, 6(3), 267–285.Google Scholar
  65. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., et al. (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature, 378(6559), 789–792.PubMedCrossRefGoogle Scholar

Copyright information

© National Society of Genetic Counselors, Inc. 2008

Authors and Affiliations

  1. 1.Division of Population ScienceFox Chase Cancer CenterPhiladelphiaUSA

Personalised recommendations